Parallel Advisors’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-200
Closed 3384
2021
Q3
$0 Hold
200
﹤0.01% 3347
2021
Q2
$0 Buy
+200
New +$450 ﹤0.01% 3108

Other funds holding ATIP.WS

Parallel Advisors's ATIP.WS Position: Q4 2021 in Review

Parallel Advisors sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q4 2021, closing a stake of 200 shares.

Parallel Advisors first reported a position in ATIP.WS in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2021. 22 funds tracked by Wall St. Rank hold ATIP.WS as of Q4 2021.

  • Parallel Advisors reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • Parallel Advisors sold 200 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2021.
  • Parallel Advisors first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
  • Parallel Advisors's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $0 in Q3 2021.
  • 22 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2021.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.